HIV ePharmacotherapy Network -

Preceptorship

Residency

Fellowship

Certificate

Research

Go To:

Main Menu

Editorial Board

- General

- International

Short Case Studies

- Submit Short Case

- View All Cases

- Search Database

Ask The Experts

Member Login

- HIV Cert. Program

- Administrators Only

Site Information

You do not have JavaScript enabled. Some portions of this website will not work properly without it. Please click here to find out how to enable JavaScript on your browser.

University at Buffalo, the State University of New York School of Pharmacy and Pharmaceutical Sciences

What's New

A new HIV Pharmacotherapy Resident begins at Erie County Medical Center Immunodeficiency Services Program - Dr. Aesha Alkebulan begins this specialty residency after completing a general practice residency at the University of Pittsburg Medical Center.
New HIV Pharmacotherapy Co-infection Clinic initiated - the first specialty pharmacotherapy clinic for patients co-infected with HIV and hepatitis has opened at the Erie County Medical Center in Western New York.
Grant obtained from the Center for Development of Human Services to study medication adherence barriers in pediatric and adolescent HIV patients at Women and Children's Hospital of Buffalo.
International HIV Pharmacology Fellow, Dr. Chiedza Maponga, presents poster on Zimbabwe adherence initiatives at 2nd International AIDS Society Conference, Paris, France.
HIV Drug Interactions and TDM registry abstract accepted for platform presentation at the annual meeting of the American College of Clinical Pharmacy, Atlanta GA, November 2003.
The HIV Drug Interactions and TDM Registry (http://tdm.buffalo.edu) welcomes new members including: Hartford Hospital, Hartford CT, Grady Health System, Atlanta GA and Clinical Research Institute, Boston MA.

Introductory HIV Pharmaceutical Care Certificate Program

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has developed a Certificate Program to provide training for pharmacists seeking the knowledge and skills necessary to assess, counsel and manage the medications of patients living with HIV infection and other common co-morbidity. The basic pathophysiology of HIV and pharmacology of antiretrovirals will be covered as well as contemporary issues in patient management such as adherence, adverse drug reactions, drug interactions, antiretroviral resistance, and therapeutic drug monitoring.

The Certificate Program will be a unique integration of didactic and experiential training, combining live and internet-based material with an experiential component.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences and HIV Pharmacotherapy Network acknowledges Agouron Pharmaceuticals for providing an unrestricted educational grant in full support of these programs.

HIV Drug Interactions & TDM Registry

The widespread use of HIV-1 protease inhibitors and non-nucleoside reverse transcriptase inhibitors as components of HAART regimens has been successful at reducing viral replication and prolonging life. However, all of the current protease inhibitors are prescribed according to fixed-dose regimens, even though considerable variation exists among individuals with regard to absorption, distribution and metabolism. Furthermore, protease inhibitors are being used in a variety of clinical scenarios that are distinct from investigational protocols such as new combination regimens, patients with end-organ dysfunction such as those with co-infection with hepatitis B and/or C and other concomitant disease states. Learn more by going to http://tdm.buffalo.edu